Roche files EUA for SARS-CoV-2 rapid antigen test

By LabPulse.com staff writers

February 8, 2021 -- Roche has filed an emergency use authorization (EUA) with the U.S. Food and Drug Administration (FDA) for its SARS-CoV-2 rapid antigen test designed for use by healthcare professionals in point-of-care settings.

The test is designed to help healthcare professionals identify a SARS-CoV-2 infection in 15 minutes for those exhibiting symptoms. The test uses a nasal swab sample and comes in a small kit that does not require laboratory instruments, Roche said.

Accompanying the test launch, Roche is offering Navify Pass, an app for healthcare providers and test recipients to share diagnostic results in real time with interested parties.

The firm expects to have tens of millions of SARS-CoV-2 rapid antigen tests available per month in the U.S. with the capacity to produce additional volumes as needed. Roche is partnering with SD Biosensor to distribute the test.

One year later, lab specialists reflect on life in the shadow of COVID-19
It all started with ominous reports at the end of 2019 about a highly contagious virus that had emerged in Wuhan, China, seemingly a world away. But a...
Bottlenecks in testing supplies short-circuit U.S. COVID-19 response
Supply shortages have plagued the U.S. response to COVID-19 testing, and the federal government is open to new ideas for solutions, according to a presentation...
Roche sees alignment between COVID-19 tests, vaccines in 2021
The distribution of COVID-19 vaccines has prompted diagnostics developers to focus on how they can continue to contribute once vaccines render millions...
Another study finds coronavirus antibody tests lacking
A comparative study of tests to detect antibodies for SARS-CoV-2 infection found that results did not live up to product claims and a combination of assays...
Roche's semiquantitative COVID-19 antibody test gets green light from FDA
Roche's semiquantitative Elecsys Anti-SARS-CoV-2 S antibody test has received an emergency use authorization from the U.S. Food and Drug Administration...

Copyright © 2021 LabPulse.com

Last Updated ls 2/8/2021 7:42:23 PM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current